By Karen Ellis Carr, Arent Fox
On December 21, 2018, the U.S. Department of Agriculture (USDA) Agricultural Marketing Service (AMS or Agency) issued its final rule establishing a National Bioengineered (BE) Food Disclosure Standard (NBFDS). The rule implements amendments to the Agricultural Marketing Act made by Public Law 114-216 on July 29, 2016 (the Act) and follows an initial request for comment by AMS on June 28, 2017 and publication of a proposed rule on May 4, 2018. This two-part article summarizes key provisions of this new federal marketing standard, including the Agency’s approach to defining “bioengineered foods” and addressing refined ingredients, voluntary labeling, absence claims, and the applicable disclosure threshold. Part 1 discussed compliance deadlines, responsible parties, definitions, AMS’ list of bioengineered foods, and exemptions from the rule. In this Part 2, we’ll cover disclosure options, voluntary disclosure, absence claims, administrative issues, and enforcement.
The rule incorporates the four disclosure options provided in the Act: text, symbol, electronic or digital link, and text message. The BE disclosure must appear on the information panel or the principal display panel of the product label, or on an alternate label panel if those panels contain insufficient space.
The rule also provides options for disclosure in certain special cases:
In response to a comment requesting an alternative website disclosure option, AMS indicated that, while it does not have the authority to require such a disclosure, regulated entities are free to include BE disclosures on their websites.
AMS agrees that voluntary BE disclosure is permissible under the Act, and the rule makes voluntary disclosure available to exempt entities and to foods in which rDNA material is not detectable but which are derived from BE crops or foods.
Entities that are otherwise exempt from the requirements of the NBFDS (very small food manufacturers, and restaurants and similar retail food establishments) may voluntarily provide disclosure of BE food that would otherwise be subject to disclosure under the NBFDS. In order to provide consistency with mandatory disclosure requirements and avoid consumer confusion, voluntary disclosure must be in one or more of the forms specified in the rule for mandatory disclosure (i.e., text, symbol, digital or electronic link, text message, or appropriate small manufacturer and small or very small package disclosure options, as applicable).
For those foods or food ingredients that (A) do not meet the definition of “bioengineered food,” (B) are not exempt from disclosure under the rule, and (C) are derived from a food on the List (described in Part 1), regulated entities may disclose such foods with one of the BE disclosure options described in the rule (text, symbol, electronic or digital link, text message, or appropriate small manufacturer and small or very small package disclosure options, as applicable). Such voluntary disclosures must state either that the food is “derived from bioengineering” or contains “ingredient(s) derived from a bioengineered source,” although “ingredient” may be replaced with the name of the specific BE crop or ingredient or may use the designated voluntary disclosure symbol.
Voluntary BE disclosure is prohibited for foods that are exempt from mandatory disclosure. For example, a regulated entity could not voluntarily disclose BE content for organic foods or for foods whose BE content falls below the 5 percent inadvertent presence threshold, or for foods that are derived from animals fed BE feed (and are not otherwise subject to disclosure).
AMS received a number of comments with respect to claims regarding the absence of bioengineering in food. In response, AMS notes that while the NBFDS covers mandatory and voluntary BE and BE-derived claims, the Act does not provide authority for AMS to establish an absence claims regime as part of the NBFDS. AMS also notes that FDA and, for certain products, USDA’s Food Safety Inspection Service retain authority over absence claims and that “[e]ntities seeking to use absence claims should ensure that such claims are in compliance with all applicable Federal laws and regulations and are otherwise truthful and not misleading.” Finally, while foods certified under the National Organic Program are exempt from the BE disclosure requirement, AMS states that the Act does not give the Agency the “authority to establish or align the NBFDS with a non-GMO label.”
AMS acknowledges that entities may participate in voluntary labeling initiatives such as the non-GMO Project so long as they are in compliance with all applicable Federal laws and regulations. To the degree possible, USDA has tried to minimize the impact the NBFDS will have on these voluntary absence claims. AMS acknowledges that some elements of the NBFDS may differ from requirements of some existing voluntary marketing claims. The Agency also notes that it has adopted the statutory definition of “bioengineering,” thereby exempting from disclosure foods such as refined products that have undergone processes that remove modified genetic material.
AMS repeatedly states that nothing in the rule prohibits regulated entities from providing additional statements or other claims regarding BE foods and BE food ingredients provided such statements are consistent with all applicable laws and regulations.
The rule provides regulated entities with significant flexibility with respect to recordkeeping, requiring maintenance of records that are “customary or reasonable” to demonstrate compliance. Such entities must maintain records for at least two years beyond the date the product is sold or distributed for retail sale. Entities must respond to AMS requests for records by providing records within five (5) business days of the request, unless AMS extends the deadline. AMS will provide prior notice of at least three (3) business days in advance of on-site inspections. Entities must provide AMS access to facilities necessary for records examinations.
The rule provides a process for any interested person with knowledge of a possible violation to file a statement or complaint with AMS. AMS may enforce compliance through an investigation that includes records audits and examinations or similar activity, either on its own initiative or in response to a complaint from a third party. If the entity that is the subject of such an investigation objects to any findings made by AMS, it may request a hearing in accordance with the rule. If the entity subject to the investigation does not request a hearing, or at the conclusion of a hearing and any subsequent revision of the findings made by AMS, the Agency will make the summary of the final results of the investigation public. The decision to make that summary public constitutes final agency action for purposes of judicial review. AMS does not have authority to issue civil penalties for violations.
The published version of the final rule and preamble (63 pages) can be accessed here:
About The Author:
Karen Ellis Carr is a partner at Arent Fox. She focuses her food and agriculture practice on regulatory counseling and litigation related to products regulated by USDA, EPA, and FDA. Carr works on issues related to biotechnology and other agricultural technologies, pesticides, food safety, advertising, and labeling, and environmental law. In addition to her work with individual companies, Carr has represented a number of industry associations on development and coordination of regulatory strategy, in litigation, and on federal and state legislative issues. She has first- and second-chaired matters in state and federal trial and appellate courts throughout the country and in arbitration and mediation, and has experience in all phases of litigation from pre-litigation strategy and counseling to settlement negotiation and appeals.